This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Goudie, A. J. Articles by Leathley, M. J. Search for Related Content PubMed Articles by Goudie, A. J. Articles by Leathley, M. J. Social Bookmarking                         What's this?

Assessment of the dependence potential of the potent high-efficacy 5-HT1A agonist S-14506 in rats

Department of Psychology, Liverpool University, P.O. Box 147, Liverpool L69 3BX, UK

Michael J. Leathley

Department of Psychology, Liverpool University, P.O. Box 147, Liverpool L69 3BX, UK

This study assessed the dependence potential of S-14506 [ 1- [ 2-(4-fluorobenzoylamino)ethyl]-4-(7-methoxy napthyl) piperazine], a novel, potent 5-HT_1A full agonist with anxiolytic and antidepressant actions in animal models. The dependence potential of S-14506 was compared with that of the benzodiazepine (BZ) chlordiazepoxide (CDP). BZ withdrawal caused weight loss, aphagia and hyperthermia after chronic b.i.d. treatment for 21 days. None of these withdrawal effects were seen after similar b.i.d. S-14506 treatment at high doses. However, the acute pharmacological actions of CDP and S-14506 differed on a number of indices. Specifically, CDP increased food intake and body weight, whilst S-14506 decreased these measures, possibly due to the induction of the serotonin syndrome. Of particular interest was the observation that S-14506 induced marked hypothermia, to which complete tolerance developed very rapidly (after only 1 day). The observation of marked, rapid tolerance to S-14506-induced hypothermia, in conjunction with the absence of withdrawal hyperthermia after prolonged chronic treatment at high doses, suggests that tolerance to this effect of S-14506 can be dissociated from dependence. Collectively, the data reported suggest that the full 5-HT_1A agonist S-14506 is devoid of dependence potential, other human and animal studies having previously suggested that partial 5-HT_1A agonists typically induce no, or minimal, dependence.

Key Words: 5-HT1A agonists • S-14506 • anxiolytics • antidepressants • benzodiazepines • dependence • tolerance

Journal of Psychopharmacology, Vol. 8, No. 4, 213-221 (1994)
DOI: 10.1177/026988119400800404


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?